Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2
The Lancet Healthy Longevity
- High-dose inactivated influenza vaccine
- Immune response
- Influenza
- Pneumonia
- Hospital Frailty Risk score
- Humans
The paper
Espersen C, Johansen ND, Modin D et al.
The Lancet Healthy Longevity · 17 Sep 2026
